Nasal cannabidiol compositions
AssigneeCurantis UG
InventorFrank-Markus LEWEKE
Life of this patent
Estimating the term…
Abstract
A nasally administered cannabinoid semi-solid or viscous liquid composition; nasal methods for administering the nasal pharmaceutical compositions; methods for manufacturing the nasal pharmaceutical compositions; and nasal methods of treating diseases treatable by the nasal pharmaceutical compositions formulated with a cannabinoid or mixtures thereof.
Claims7
A method of treating a disorder schizophrenia in a subject, comprising nasally administering a nasal pharmaceutical composition into at least one nostril of the subject at least once per day in an amount effective to treat schizophrenia the subject's disorder and/or alleviate or reduce the subject's symptoms thereof, wherein, the nasal pharmaceutical composition comprises:
- (a) a therapeutically effective amount of cannabinoid;
- and
- (b) a pharmaceutically acceptable oily vehicle;
- wherein the nasal pharmaceutical composition is a semi-solid or viscous liquid nasal pharmaceutical composition having a viscosity within a viscosity range of between 500 cps and 100,000 cps;
- wherein the cannabinoid comprises at least 5 mg of CBD, and
- wherein the oily vehicle is selected from the group consisting of Aloe Vera Oil (Aloe barbadensis), Argan Oil (Argania spinosa), Avocado Oil (Persea americana), Apricot Oil (Prunus armeniaca), Carrot Oil (Daucus carota), Coconut Oil (Cocus nucifera), Corn Oil, Cucumber Oil (Cucumis sativa), Chaulmoogra Oil (Hydnocarpus wightianus), Flaxseed Oil (Linum usitatissimum), Triticum vulgare, Macadamia Oil (Macadamia ternifolia), Pomegranate Oil, Punica granatum, Rosehip Seed Oil (Rosa rubiginosa), Sea Buckthorn Oil (Hippophae rhamnoides), Seet Cherry Kernel Oil (Prunus avium), Castor Oil, sesame oil, and sucrose acetate isobutyrate (SAIB).
Dependencies are inferred from the claim text.